Cargando…

Lipid Metabolism Regulates Oxidative Stress and Ferroptosis in RAS-Driven Cancers: A Perspective on Cancer Progression and Therapy

HRAS, NRAS and KRAS, collectively referred to as oncogenic RAS, are the most frequently mutated driver proto-oncogenes in cancer. Oncogenic RAS aberrantly rewires metabolic pathways promoting the generation of intracellular reactive oxygen species (ROS). In particular, lipids have gained increasing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartolacci, Caterina, Andreani, Cristina, El-Gammal, Yasmin, Scaglioni, Pier Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415548/ https://www.ncbi.nlm.nih.gov/pubmed/34485382 http://dx.doi.org/10.3389/fmolb.2021.706650

Ejemplares similares

Ferroptosis: A Specific Vulnerability of RAS-Driven Cancers?
por: Andreani, Cristina, et al.
Publicado: (2022)

Current progress of ferroptosis study in ovarian cancer
por: Tan, Zhuomin, et al.
Publicado: (2022)

Ferroptosis Biology and Implication in Cancers
por: Qu, Chi, et al.
Publicado: (2022)

Editorial: Ferroptosis in cancer and beyond
por: Wang, Xin, et al.
Publicado: (2023)

Radiotherapy-induced ferroptosis for cancer treatment
por: Beretta, Giovanni L., et al.
Publicado: (2023)

RAS Nanoclusters Selectively Sort Distinct Lipid Headgroups and Acyl Chains
por: Zhou, Yong, et al.
Publicado: (2021)

Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
por: Li, Lanqing, et al.
Publicado: (2022)

Ferroptosis and its emerging role in esophageal cancer
por: Maimaitizunong, Rezeye, et al.
Publicado: (2022)

Ferroptosis: Opportunities and Challenges in Treating Endometrial Cancer
por: Wu, Jianfa, et al.
Publicado: (2022)

Ferroptosis: Mechanism and potential applications in cervical cancer
por: Chang, Xiangyu, et al.
Publicado: (2023)

Editorial: Ferroptosis in cancer and Beyond—volume II
por: Wang, Xin, et al.
Publicado: (2023)

Regulation mechanism of ferroptosis and its research progress in tumor immunotherapy
por: Xu, Jing, et al.
Publicado: (2022)

Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis
por: Tang, Rui, et al.
Publicado: (2023)

Iron regulatory proteins: players or pawns in ferroptosis and cancer?
por: Cardona, Cameron J., et al.
Publicado: (2023)

Single-cell transcriptomics uncover the key ferroptosis regulators contribute to cancer progression in head and neck squamous cell carcinoma
por: Liu, Fei, et al.
Publicado: (2022)

Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis
por: Shi, Hanqiang, et al.
Publicado: (2023)

Crosstalk between ferroptosis and steroid hormone signaling in gynecologic cancers
por: Lai, Wen, et al.
Publicado: (2023)

K-RAS4A: Lead or Supporting Role in Cancer Biology?
por: Aran, Veronica
Publicado: (2021)

Editorial: Ras and Other GTPases in Cancer: From Basic to Applied Research
por: Cho, Kwang-jin, et al.
Publicado: (2021)

The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells
por: Tisi, Renata, et al.
Publicado: (2021)

Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2022)

Biological Functions and Prognostic Value of Ferroptosis-Related Genes in Bladder Cancer
por: Yi, Kezhen, et al.
Publicado: (2021)

Screening of ferroptosis-related genes with prognostic effect in colorectal cancer by bioinformatic analysis
por: Hu, Dongzhi, et al.
Publicado: (2022)

Ferroptosis-related genes in cervical cancer as biomarkers for predicting the prognosis of gynecological tumors
por: Han, Songtao, et al.
Publicado: (2023)

The potential interplay between G-quadruplex and p53: their roles in regulation of ferroptosis in cancer
por: Zhang, Lulu, et al.
Publicado: (2022)

Screening for Potential Therapeutic Agents for Non-Small Cell Lung Cancer by Targeting Ferroptosis
por: Zhao, Xin, et al.
Publicado: (2022)

ELOVL5 and IGFBP6 genes modulate sensitivity of breast cancer cells to ferroptosis
por: Nikulin, Sergey, et al.
Publicado: (2023)

Mechanisms and inhibitors of ferroptosis in psoriasis
por: Zhou, Qiao, et al.
Publicado: (2022)

The role of microRNAs in ferroptosis
por: Guo, Liqing, et al.
Publicado: (2022)

A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer
por: Ye, Ying, et al.
Publicado: (2021)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2021)

Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
por: Shu, Xiangjun, et al.
Publicado: (2022)

Identification of a Novel Ferroptosis Inducer for Gastric Cancer Treatment Using Drug Repurposing Strategy
por: Zhang, Jinping, et al.
Publicado: (2022)

Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: Existing evidence and future directions
por: Tan, Xin, et al.
Publicado: (2022)

Enzalutamide-Resistant Progression of Castration-Resistant Prostate Cancer Is Driven via the JAK2/STAT1-Dependent Pathway
por: Luo, Yong, et al.
Publicado: (2021)

Blocking K-Ras Interaction With the Plasma Membrane Is a Tractable Therapeutic Approach to Inhibit Oncogenic K-Ras Activity
por: Henkels, Karen M., et al.
Publicado: (2021)

Therapeutic Implications of Ferroptosis in Renal Fibrosis
por: Zhang, Yao, et al.
Publicado: (2022)

Neuronal ferroptosis after intracerebral hemorrhage
por: Ren, Siying, et al.
Publicado: (2022)

Mechanisms of ferroptosis in chronic kidney disease
por: Zhuo, Wen-Qing, et al.
Publicado: (2022)

The Role of Ferroptosis in Acute Kidney Injury
por: Zhang, Jinshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eq8jki7ujr2l0mb4lhk2d3c07f